These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36343430)

  • 21. Knowledge of Good Samaritan Laws and Beliefs About Arrests Among Persons Who Inject Drugs a Year After Policy Change in Baltimore, Maryland.
    Schneider KE; Park JN; Allen ST; Weir BW; Sherman SG
    Public Health Rep; 2020; 135(3):393-400. PubMed ID: 32264789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Initial evaluation of law enforcement overdose training in Rhode Island.
    Saucier CD; Zaller N; Macmadu A; Green TC
    Drug Alcohol Depend; 2016 May; 162():211-8. PubMed ID: 27020323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically.
    Evans TI; Hadland SE; Clark MA; Green TC; Marshall BD
    Harm Reduct J; 2016 Jul; 13(1):24. PubMed ID: 27455957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Law enforcement attitudes toward overdose prevention and response.
    Green TC; Zaller N; Palacios WR; Bowman SE; Ray M; Heimer R; Case P
    Drug Alcohol Depend; 2013 Dec; 133(2):677-84. PubMed ID: 24051061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
    Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey of naloxone legal status in opioid overdose prevention and treatment.
    Hewlett L; Wermeling DP
    J Opioid Manag; 2013; 9(5):369-77. PubMed ID: 24353049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional variation in states' naloxone accessibility laws in association with opioid overdose death rates-Observational study (STROBE compliant).
    You HS; Ha J; Kang CY; Kim L; Kim J; Shen JJ; Park SM; Chun SY; Hwang J; Yamashita T; Lee SW; Dounis G; Lee YJ; Han DH; Byun D; Yoo JW; Kang HT
    Medicine (Baltimore); 2020 May; 99(22):e20033. PubMed ID: 32481373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A modified Delphi process to identify experts' perceptions of the most beneficial and harmful laws to reduce opioid-related harm.
    Hamilton LK; Wheeler-Martin K; Davis CS; Martins SS; Samples H; Cerdá M
    Int J Drug Policy; 2022 Oct; 108():103809. PubMed ID: 35908313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Good Samaritan harm reduction policy and drug overdose deaths.
    Atkins DN; Durrance CP; Kim Y
    Health Serv Res; 2019 Apr; 54(2):407-416. PubMed ID: 30740691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleeding Control Protections Within US Good Samaritan Laws.
    Levy MJ; Wend CM; Flemming WP; Lazieh A; Rosenblum AJ; Pineda CM; Wolfberg DM; Jenkins JL; Goolsby CA; Margolis AM
    Prehosp Disaster Med; 2024 Apr; 39(2):156-162. PubMed ID: 38572644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration.
    Davis CS; Carr D; Southwell JK; Beletsky L
    Am J Public Health; 2015 Aug; 105(8):1530-7. PubMed ID: 26066921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of events in which police responded to overdoses: an examination of incident reports in Rhode Island.
    Macmadu A; Yolken A; Frueh L; Toussaint JR; Newman R; Jacka BP; Collins AB; Marshall BDL
    Harm Reduct J; 2022 Oct; 19(1):116. PubMed ID: 36258209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State-by-State Examination of Overdose Medical Amnesty Laws.
    Griner TE; Strasser S; Kemp CB; Zesiger H
    J Leg Med; 2020; 40(2):171-193. PubMed ID: 33137279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "The Law Doesn't Protect Me": Examining the Effectiveness of Good Samaritan Drug Overdose Legislation.
    van der Meulen E; Chu SKH
    Subst Use Misuse; 2022; 57(9):1392-1399. PubMed ID: 35676857
    [No Abstract]   [Full Text] [Related]  

  • 35. A national survey of law enforcement post-overdose response efforts.
    Ray B; Richardson NJ; Attaway PR; Smiley-McDonald HM; Davidson P; Kral AH
    Am J Drug Alcohol Abuse; 2023 Mar; 49(2):199-205. PubMed ID: 36820614
    [No Abstract]   [Full Text] [Related]  

  • 36. Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid.
    Gertner AK; Domino ME; Davis CS
    Drug Alcohol Depend; 2018 Sep; 190():37-41. PubMed ID: 29966851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Law enforcement attitudes towards naloxone following opioid overdose training.
    Purviance D; Ray B; Tracy A; Southard E
    Subst Abus; 2017; 38(2):177-182. PubMed ID: 27715714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System.
    Grover JM; Alabdrabalnabi T; Patel MD; Bachman MW; Platts-Mills TF; Cabanas JG; Williams JG
    Prehosp Emerg Care; 2018; 22(3):281-289. PubMed ID: 29297739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing law from barrier to facilitator of opioid overdose prevention.
    Davis C; Webb D; Burris S
    J Law Med Ethics; 2013 Mar; 41 Suppl 1():33-6. PubMed ID: 23590737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States.
    Sohn M; Talbert JC; Huang Z; Lofwall MR; Freeman PR
    JAMA Netw Open; 2019 Jun; 2(6):e196215. PubMed ID: 31225895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.